sellWeak cluster of 210b5-1 plan
MAHON PAUL A sold $2.8M of UTHR
EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp. 7,700 shares at an average of $367.36, traded Nov 21, 2024, filed Nov 22, 2024.
Warning score
18Value
$2.8M
7,700 shares
Holdings after
36,710
-17% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001562180-24-007878, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | MOption exercise Common Stock10b5-1 | +7,700 | $163.30 | $1.3M | 44,410 | Nov 22, 2024 |
| Nov 21, 2024 | SOpen-market sale Common Stock10b5-1 | -7,700 | $367.36 | $2.8M | 36,710 | Nov 22, 2024 |
| Nov 21, 2024 | MOption exercise Share Tracking Awardderivative10b5-1 | -7,700 | $0.00 | $0 | 52,750 | Nov 22, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 18Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A EVP & GENERAL COUNSEL | $2.9M | 7,700 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 45Moderate | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 45Moderate | sell 510b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $6.1M | 15,000 | |
| 45Moderate | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $10.0M | 25,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.